EVP Vanessa Broadhurst sold 6,197 JNJ shares at $243.39 on 2026-02-17; holds 23,003 post-transaction. Prior JNJ sell was well-timed (-9.0% to -9.5% return).
Broadhurst's sale of 6,197 shares represents a 21.2% reduction in her JNJ position, executed at $243.39 while the stock currently trades at $244.99, near its 52-week high. Her single prior transaction in JNJ (a sale in March 2024) generated negative 90-day returns of -9.5%, ranking as well-timed per her cross-ticker track record of 100.0% well-timed sells. However, the cross-ticker track record is limited to 1 prior sell with an average 90-day return of -9.5%, making it a thin basis for pattern inference. The company's fundamentals remain solid: $24.0B in quarterly revenue, $5.2B net income, 6.0% annual growth, and a P/E of 15.59 at a $590.4B market cap. This transaction signals a material reduction in holdings rather than a minor rebalancing, yet without disclosed rationale or FLAGS indicating a 10b5-1 plan, the timing cannot be characterized strategically.